Naproxen Tablets(Cr) Suppliers & Bulk Manufacturers

Available Forms: CR tablets

Available Strengths: 375 mg, 500 mg, 750 mg

Reference Brands: Naprelan(US)

Category: Arthritis

Naproxen CR tablets inhibit cyclooxygenase enzymes (COX-1 and COX-2), reducing prostaglandin production, which alleviates pain and inflammation. The controlled-release formulation provides long-lasting effects, reducing dosing frequency. Benefits include sustained relief from arthritis pain, inflammation, and fever, with improved compliance and a reliable safety profile when used as directed. Naproxen tablets(CR) is available in CR tablets and strengths such as 375 mg, 500 mg, 750 mg. Sourced from GMP-certified and ISO-compliant manufacturers, this API meets global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical formulation and commercial manufacturing, Naproxen tablets(CR) is supplied in bulk quantities with complete regulatory support including DMF, COA, and MSDS.

Naproxen tablets(CR) can be exported to over 30 countries across Asia, Africa, Europe, and Latin America. Flexible packaging, competitive pricing, and a verified supplier network make Pharmatradz a trusted sourcing partner for pharmaceutical companies and contract manufacturers worldwide.

Product Description: Naproxen CR (Controlled Release) tablets are approved in the EU and US for pain, inflammation, and rheumatoid arthritis. In the EU, brands like Naprelan are regulated by EMA, supported by dossiers demonstrating safety, efficacy, and manufacturing standards. In the US, FDA approval relies on extensive clinical data, with generic versions available. Both regions require detailed dossiers for initial approval and ongoing pharmacovigilance. For expert assistance with regulatory dossiers, compliance, and registration, visit PharmaTradz. We support efficient market access for naproxen CR tablets, ensuring adherence to European and American standards for safe, effective anti-inflammatory therapy.